Background/Aims: Acute myocardial infarction (AMI) occurs when blood supply to the heart is diminished (ischemia) for long time; ischemia is primarily caused due to hypoxia. The present study evaluated the effects of long non-coding RNA H19 on hypoxic rat H9c2 cells and mouse HL-1 cells. Methods: Hypoxic injury was confirmed by measuring cell viability, migration and invasion, and apoptosis using MTT, Transwell and flow cytometry assays, respectively. H19 expression after hypoxia was estimated by qRT-PCR. We then measured the effects of non-physiologically expressed H19, knockdown of miR-139 with or without H19 silence, and abnormally expressed Sox8 on hypoxia-induced H9c2 cells. Moreover, the interacted miRNA for H19 and downstream target gene were virtually screened and verified. The involved signaling pathways and the effects of abnormally expressed H19 on contractility of HL-1 cells were explored via Western blot analysis. Results: Hypoxia induced decreases of cell viability, migration and invasion, increase of cell apoptosis and up-regulation of H19. Knockdown of H19 increased hypoxia-induced injury in H9c2 cells. H19 acted as a sponge for miR-139 and H19 knockdown aggravated hypoxia-induced injury by up-regulating miR-139. Sox8 was identified as a target of miR-139, and its expression was negatively regulated by miR-139. The mechanistic studies revealed that overexpression of Sox8 might decrease hypoxia-induced cell injury by activating the PI3K/AKT/mTOR pathway and MAPK. Besides, H19 promoted contractility of HL-1 cells. Conclusion: These findings suggest that H19 alleviates hypoxia-induced myocardial cell injury by miR-139-mediated up-regulation of Sox8, along with activation of the PI3K/AKT/mTOR pathway and MAPK.
Introduction
Acute myocardial infarction (AMI) is one of the most severe manifestations of coronary artery diseases that causes irreversible damage to the heart muscle, and can lead to development of heart failure [1, 2] . AMI leads to more than 4 million deaths in Europe and northern Asia [3] . AMI is traditionally divided into ST elevation and non-ST elevation myocardial infarction (MI) [4] . Generally, MI occurs due to prolonged ischemic condition (diminished blood supply to the heart). Myocardial ischemia occurs due to increased myocardial metabolic demand, and/or decreased delivery of oxygen (hypoxia) and nutrients to the myocardium via the coronary circulation [5] . Therefore, the regulation of hypoxiainduced injury to the myocardium and the underlying molecular mechanism are of great importance.
Long non-coding RNAs (lncRNAs) are a diverse class of non-protein-coding transcripts, which play important roles in various biological processes [6, 7] . These biological processes regulated by lncRNAs include invasion, metastasis, apoptosis, DNA damage, angiogenesis, microRNA (miR/miRNA) silencing, embryonic development, cardiac aging and tumor development [8] [9] [10] [11] . Recently, few literatures have focused on the role of lncRNAs in AMI. For instance, circulating level of lncRNA ZFAS1 in AMI subjects was significantly lower than that in non-AMI subjects, whereas the level of lncRNA CDR1AS in AMI subjects was higher than that in non-AMI subjects [12] . Vausort et al. studied expressions of five different lncRNAs in patients with MI, and showed that several lncRNAs were aberrantly expressed in MI patients [13] . Another study also stated that lncRNA UCA1 promoted cardiomyocyte apoptosis by inhibiting p27 expression [14] .
The lncRNA H19, a 2.3 kb lncRNA transcribed from the H19 gene, is highly expressed in several tissues of fetus, but the expression is significantly reduced after birth [15, 16] . Researchers have reported contradictory functions of H19, especially in cancer [15, [17] [18] [19] [20] . Initially, H19 is identified as a tumor suppressor [21] , however, mounting studies have reported that H19 is overexpressed in multiple types of cancers, including breast cancer [17] , bladder cancer [18] , and cervical carcinoma [19] . Role of H19 in cell injury has been evaluated in very few studies, for instance, Kim et al. reported that H19 is re-expressed in rat vascular smooth muscle cells after injury [20] . To our knowledge, very little is known about the functional roles of H19 in hypoxic injury to myocardial cells. Here, we studied the expression of H19 in hypoxic rat myocardial H9c2 cells. In addition, we studied the functions and the possible underlying molecular mechanisms of H19 in hypoxic H9c2 cells. Besides, the effects of abnormally expressed H19 on contractility of mouse HL-1 cells were also investigated.
Materials and Methods
Cell culture and treatment H9c2 cells, derived from rat embryonic ventricular cardiomyocytes, were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, and 100 µg/ml streptomycin (all from Gibco, Carlsbad, CA, USA). Mouse cardiomyocyte HL-1 cells were maintained in Claycomb medium containing 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine and 0.1 mM noradrenaline (Sigma-Aldrich, St Louis, MO, USA). For normoxic condition, cells were maintained at 37°C in an atmosphere of 95% air and 5% CO 2 . To stimulate hypoxia, cells were incubated in a hypoxic incubator containing 94% N 2 , 5% CO 2 , and 1% O 2 .
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA was extracted from cells using Trizol reagent (Life Technologies Corporation, Carlsbad, CA, USA) according to the manufacturer's instructions. The expression level of H19 was measured by using One
Step Cell transfection Short-hairpin (sh) RNAs directed against H19 or Sox8, or non-targeting sequence was ligated into the U6/GFP/Neo plasmids (GenePharma, Shanghai, China) and the resultant plasmids were referred to as sh-H19, sh-Sox8 or shNC. Full-length H19 sequences and Sox8 sequences were sub-cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) and pEX-2 plasmids (GenePharma), respectively, and the resultant plasmids were referred to as pc-H19 and pEX-Sox8. Lipofectamine 3000 reagent (Life Technologies Corporation) was used for cell transfection according to the manufacturer's instructions. The stably transfected cells were selected by the culture medium containing 0.5 mg/ml G418 (Sigma-Aldrich). Scramble miRs, miR-139 mimic, miR-139 inhibitor and its negative control (NC), synthesized by Life Technologies Corporation, were transfected into cells using Lipofectamine 3000 reagent and the transfected cells were harvested at 72 h post-transfection.
Cell viability, migration and invasion assays
Cell viability was assessed by using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. In brief, cells (1 × 10 5 cells/well) were seeded into 96-well plates and cultured at 37°C. After treatments, 20 μl MTT solution (5 mg/ml; Sigma-Aldrich) was added into each well at 12 h, 24 h, 72 h and 96 h post-hypoxia, and the mixture was incubated at 37°C for additional 4 h. After addition of 100 μl dimethyl sulfoxide, absorbance was read using a Microplate reader (Bio-rad, Hercules, CA, USA) at 570 nm.
Cell migration was determined using a modified two-chamber migration assay with a pore size of 8 μm. Cells suspended in 200 μl of serum-free medium were seeded on the upper compartment of 24-well Transwell culture chamber, and 600 μl of complete medium was added to the lower compartment. After incubation at 37°C, cells were fixed with methanol. Non-traversed cells were removed from the upper surface of the filter carefully with a cotton swab. Traversed cells on the lower side of the filter were stained with crystal violet and counted. The protocol of cell invasion was consistent with that of cell migration except that the membranes were pre-coated with Matrigel (BD Biosciences, San Jose, CA, USA).
Apoptosis assay
Cell apoptosis analysis was performed using propidium iodide (PI) and fluorescein isothiocynate (FITC)-conjugated Annexin V staining. Briefly, cells were washed in phosphate buffered saline (PBS), suspended in binding buffer, and stained in PI and FITC-Annexin V in the presence of 50 μg/ml RNase A (Sigma-Aldrich) according to the manufacturer's instructions. Flow cytometry analysis was done using a FACScan (Beckman Coulter, Fullerton, CA, USA). Data were analyzed using FlowJo software (Tree Star, San Carlos, CA, USA).
Luciferase reporter assay
The fragment from Sox8 3'-untranslated region (3'UTR) containing the predicted miR-139 binding site was cloned into pmirGLO vector (Promega, Madison, WI, USA) to form the reporter vector Sox8-wild-type (Sox8-Wt). To mutate the putative binding site of miR-139 in Sox8 3'UTR, site-mutations were performed to generate Sox8-mutated-type (Sox8-Mt). Then the vectors (Sox8-Wt or Sox8-Mt) and miR-139 mimics or scramble miRs were co-transfected into cells, and Dual Luciferase Reporter Assay System (Promega) was used for testing luciferase activity.
Western blot analysis
The proteins used for western blotting were extracted using RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China) and were quantified using BCA™ Protein Assay Kit (Pierce, Appleton, WI, USA). After separation using SDS-PAGE, proteins in the gels were transferred into polyvinylidene difluoride (PVDF) membranes. Then, membranes were blocked with non-fat milk and incubated with primary antibody at 4°C overnight, followed by wash and incubation with secondary antibody marked by horseradish peroxidase for 1 h at room temperature. After rinsing, the membranes were transferred into Bio-Rad ChemiDoc™ XRS system, and then 200 μl Immobilon Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA, USA) was added to cover the membrane surface. The signals were captured using Image Lab™ software (Bio-Rad).
Statistical analysis
The results of multiple experiments are presented as mean ± standard deviation (SD). Statistical analyses were performed on normalized data using Graphpad 6.0 statistical software. P values were 
Results

Hypoxia induces cell injury and up-regulation of H19 in H9c2 cells
First, we induced hypoxia in H9c2 cells by incubating the cells in a hypoxic incubator containing 94% N 2 , 5% CO 2 , and 1% O 2 . Then, cell viability, migration, invasion, and apoptosis of hypoxic H9c2 cells and normoxic cells (control) were measured. As compared to the control group, significant decreases in cell viability (P<0.01 and P<0.001 at 72 h and 96 h post-hypoxia, respectively; Fig. 1A) , migration (P<0.01; Fig. 1B) , and invasion (P<0.01; Fig.  1C ) as well as a significant increase in cell apoptosis (P<0.001; Fig. 1D ) were observed in the hypoxia groups. Western blot analysis showed that the protein expression of pro-apoptotic proteins (Bax, cleaved caspase-3, and cleaved caspase-9) was increased whereas expression of anti-apoptotic protein (Bcl-2) was decreased in hypoxic cells as compared to the control group (Fig. 1E) . Besides, results of qRT-PCR showed H19 was markedly up-regulated after hypoxia treatments compared to the control group (P<0.01; Fig. 1F ). These findings indicate that hypoxia inhibits cell viability, migration, and invasion, and promotes cell apoptosis of H9c2 cells, along with up-regulation of H19.
Hypoxia-induced cell injury is aggravated by H19 knockdown but is attenuated by H19 overexpression
Then we measured the effects of non-physiologically expressed H19 on hypoxic H9c2 cells. In Fig. 2A , expression level of H19 was significantly decreased by transfection with sh-H19 as compared to the shNC group (P<0.001). Knockdown of H19 using sh-H19 significantly decreased cell viability (P<0.01 and P<0.05 at 72 h and 96 h post-hypoxia, respectively), migration (P<0.05), and invasion (P<0.05), while significantly increased cell Further results showed the effects of H19 overexpression on cell viability, migration, invasion and cell apoptosis were opposite to that of H19 knockdown. Hypoxia-induced cell injury is aggravated by H19 knockdown but is attenuated by H19 overexpression in H9c2 cells.
H19 acts as a sponge of miR-139
Although lncRNAs are functionally and structurally different from miRs, few studies have suggested a connection between these two classes of RNAs [16, 23] . By using bioinformatics methods, miR-139 was predicted to bind to H19, and the binding sequences were shown in the Fig. 3A . To verify the possible connection between H19 and miR-139, the relative expression of miR-139 was measured in transfected cells. As shown in Fig. 3B , knockdown of H19 significantly increased the relative expression level of miR-139 as compared with the shNC group (P<0.001), suggesting that H19 negatively regulated the expression of miR-139. Results indicate that H19 can act as a sponge for miR-139.
The effects of H19 knockdown on hypoxia-induced cell injury are reversed by miR-139 suppression As miR-139 was identified as a target of H19, we studied the effects of miR-139 on hypoxia-induced cell injury with or without H19 knockdown. After cell transfection, expression level of miR-139 was significantly up-regulated by miR-139 mimic as compared to the scramble group (P<0.001; Fig. 4A ) but was markedly down-regulated by miR-139 inhibitor as compared to the NC group (P<0.001; Fig. 4B ). Then, the effects of abnormally expressed miR-139 on cell viability, migration, invasion, and apoptosis of hypoxia-treated H9c2 cells were explored. When compared to the hypoxia + NC groups, miR-139 inhibition significantly increased cell viability (both P<0.05 at 72 h and 96 h post-hypoxia; Fig. 4C ), migration (P<0.05; Fig. 4D ) and invasion (P<0.05; Fig. 4E ) but reduced cell apoptosis (P<0.01; Fig. 4F ). Likewise, hypoxia-induced alteration of apoptosis-associated proteins was reversed by miR-139 inhibition (Fig. 4G) . Subsequently, the effects of miR-139 inhibition on hypoxia-induced injury of H19-silenced H9c2 cells were further explored. As compared to the hypoxia + sh-H19 + NC groups, down-regulation of both miR-139 and H19 expressions significantly increased cell viability (both P<0.05 at 72 h and 96 h post-hypoxia; Fig. 4H ), migration (P<0.01; Fig. 4I ) and invasion (P<0.01; Fig. 4J ), but decreased cell apoptosis (P<0.05; Fig. 4K ). Likewise, H19 knockdown-induced alterations of apoptosis-associated proteins were all reversed by miR-139 inhibition (Fig. 4L) . These findings suggest that H19 knockdown aggravates hypoxia-induced cell injury through upregulating miR-139 expression.
Sox8 is negatively regulated by miR-139
Utilizing the online TargetScan software, possible target genes of miR-139 were virtually screened. Among those targets, we chose Sox8 to deeply investigate. The binding sequences between miR-139 and Sox8 3'UTR were shown in the Fig. 5A . The qRT-PCR and western blot results showed that miR-139 mimic significantly decreased the mRNA and protein expressions of Sox8 (P<0.01; Fig. 5B ) while miR-139 inhibitor increased the expression of Sox8 (P<0.001; Fig. 5C ), indicating that Sox8 was negatively regulated by miR-139 expression. Dual luciferase reporter assay was performed to verify the targeting between miR-139 and Sox8 3'UTR. As shown in Fig. 5D , luciferase activity was significantly decreased in cells co-transfected with miR-139 mimic and Sox8-Wt, as compared to the co-transfection with Sox8-Wt and scramble miRs (P<0.05). No significant changes were observed in cells co-transfected with Sox8-Mt vector. These findings suggest that Sox8 is a target of miR-139.
Overexpression of Sox8 alleviates hypoxia-induced cell injury of H9c2 cells
After stable transfection, the qRT-PCR and western blot results showed that pEX-Sox8 significantly increased the mRNA and protein expressions of Sox8 (P<0.001; Fig. 6A-6B ), while sh-Sox8 significantly decreased the expression of Sox8 (P<0.001; Fig. 6C-D) . In further Fig. 6H ) as compared to the hypoxia + pEX-2 groups. Western blot results showed the decreased expression of Bcl-2 and the increased expressions of pro-apoptotic proteins, which were induced by hypoxia, were all reversed by Sox8 overexpression (Fig. 6I) . However, the effects of Sox8 silence on hypoxia-treated cells were just the opposite. These findings suggest that overexpression of Sox8 alleviates hypoxia-induced cell injury of H9c2 cells. Western blot analysis was used to measure the expressions of apoptosis-associated proteins. Each experiment was repeated three times. *P<0.05, **P<0.01, ***P<0.001. In E, * indicates significance of comparisons compared with the hypoxia + shNC group, and # indicates significance of comparison compared with the hypoxia + pEX-2 group, #P<0.05. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; Bcl-2: mammalian B cell lymphoma-2; Bax: Bcl-2-associated X protein; sh-Sox8: short-hairpin RNA-suppressed Sox8; shNC: negative control of sh-Sox8.
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Sox8 activates the phosphoinositide 3-kinase (PI3K)/ serine-threonine kinase (AKT)/ mechanistic target of rapamycin (mTOR) pathway and mitogenactivated protein kinase (MAPK)
We then studied the underlying mechanism for the H19-asssociated modulations using western blot analysis. The results showed that overexpression of Sox8 increased the expressions of phosphorylated PI3K, AKT, mTOR, and MAPK, while the effects of Sox8 inhibition were just the opposite (Fig. 7) . These findings indicate that overexpression of Sox8 may alleviate hypoxia-induced cell injury by activating the PI3K/AKT/mTOR pathway and MAPK.
H19 overexpression up-regulates expression of sarcoplasmic reticulum Ca
2+
ATPase (SERCA2a) in HL-1 cells Considering the interaction between H19 and miR-139 as well as the interaction between miR-139 and Sox8 are existed in mice, which are shown in the Fig. 3A and Fig.  5A , we finally explored the effects of abnormally expressed H19 on contractility using mouse HL-1 cells. Interestingly, protein expression level of SERCA2a was reduced by hypoxia and further reduced by H19 silence (Fig. 8A) , whereas the down-regulation was reversed by H19 overexpression (Fig. 8B) . Results suggest that H19 promotes contractility. The final regulatory circuit of H19 in hypoxia-induced cell injury was shown in Fig. 9 .
Discussion
In the present study, we evaluated the effects and the possible underlying mechanisms of H19 expression on hypoxiainduced H9c2 cell injury. First of all, hypoxic condition induced injury to H9c2 cells by decreasing cell viability, migration and invasion, and increasing apoptosis as well as up-regulation of H19. Subsequently, hypoxia-induced cell injury was aggravated by H19 knockdown but was attenuated by H19 overexpression. In further experiments, H19 was identified as a sponge for miR-139. Interestingly, the effects of H19 knockdown on the hypoxic cells were reversed by miR-139 suppression. Sox8 was revealed to be Role of lncRNA H19 has been studied in several malignant diseases. For example, Ma et al. reported that H19 promotes proliferation of pancreatic ductal adenocarcinoma cells [24] . Yang et al. showed that overexpression of H19 increases cell proliferation and decreases apoptosis of gastric cancer cells [25] . In our study, we demonstrated that knockdown of H19 decrease cell viability, migration and invasion but increase apoptosis through mitochondrialand caspase-dependent pathways in hypoxia-treated H9c2 cells, whereas the effects of H19 overexpression were just the opposite. To our knowledge, this is the first study reporting the effects of H19 on hypoxia-injured H9c2 cells.
We found H19 silence functioned through up-regulating miR-139. In our study, H19 was markedly up-regulated after hypoxia treatments, suggesting the possible involvements in the hypoxia-induced cell injury. miRs are small, non-coding RNAs that regulate the expression of protein-encoding genes at the post-transcriptional level. Accumulating evidence has reported the key roles of miRs in the process of hypoxia-induced myocardial injury [26] [27] [28] [29] . A previous study showed expression of miR-139 was reported to be down-regulated in neurons and rat brains after hypoxia [30] . Moreover, by using bioinformatics method, human H19 was predicted to bind to miR-139-5p. Thus, we speculated that there might be an interaction between H19 and miR-139. Following results illustrated miR-139 was negatively regulated by H19, and more data proved that the H19 inhibition aggravated hypoxia-induced cell injury by up-regulating miR-139.
We then explored the possible underlying mechanism for the effects of miR-139 on the hypoxic cells. Towards this goal, putative target genes of miR-139 were screened using bioinformatics methods. Among those genes, Sox8, belonging to group E of SOX family proteins, is reported to promote cell proliferation of diverse cancer cells [31, 32] . Several researchers have reported that Sox8 is expressed in the developing heart [33, 34] . However, Sox8 has not been studied in hypoxia-induced myocardial injury. In the present study, Sox8 was identified to be a target of miR-139. Meanwhile, overexpression of Sox8 decreased hypoxia-induced cell injury by increasing cell viability, migration, and invasion and decreasing apoptosis. In further experiments, we studied effects of Sox8 on the PI3K/ AKT/mTOR signal pathway and MAPK activation. PI3K/AKT signal pathway is an important pathway for protecting myocardial cells against hypoxia-induced injury [35, 36] . Xiao et al. reported that hydrogen sulfide protects myocardial cells against hypoxia-induced injury via mTOR activation [37] . Chen et al. reported that lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation 
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and Nrf2/ARE complex [38] . Our results showed that overexpression of Sox8 might alleviate hypoxia-induced H9c2 cell injury by activating the PI3K/AKT/mTOR pathway and MAPK, which should be verified by more experiments in the future. HL-1 cells, established from the AT-1 mouse atrial cardiomyocyte tumor, are a widely used cell line which retains phenotypic characteristics of adult cardiomyocyte, such as contractile phenotype [39] . SERCA2a acting as the ATP-dependent calcium pump is reported to be a prime target for modulating cardiac contractility [40] . In our study, we finally explored the roles of non-physiologically expressed H19 in modulation of contractility by measuring the protein expression of SERC2a. Results illustrated that hypoxia inhibited contractility of HL-1 cells and the contractility was further inhibited by H19 knockdown. Conversely, H19 overexpression could promote contractility, suggesting the potential protective role of H19 in hypoxia-treated HL-1 cells.
Conclusion
In conclusion, this study demonstrated that knockdown of H19 aggravates hypoxiainduced H9c2 cell injury by decreasing cell viability, migration, and invasion and increasing cell apoptosis. Importantly, we found that H19 acted as a sponge for miR-139 and Sox8 was a target of miR-139. Furthermore, we found overexpression of Sox8 might protect H9c2 cells from hypoxia-induced injury by activating the PI3K/AKT/mTOR pathway and MAPK. Finally, H19 was identified to promote contractility in HL-1 cells. Our research is a preliminary study that might provide new insights in the prevention and treatment of AMI. More experiments should be done in other cell types of cardiomyocytes to verify the conclusions.
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